207 related articles for article (PubMed ID: 15358229)
1. AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.
Xiang X; Saha AK; Wen R; Ruderman NB; Luo Z
Biochem Biophys Res Commun; 2004 Aug; 321(1):161-7. PubMed ID: 15358229
[TBL] [Abstract][Full Text] [Related]
2. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
Baumann P; Mandl-Weber S; Emmerich B; Straka C; Schmidmaier R
Exp Cell Res; 2007 Oct; 313(16):3592-603. PubMed ID: 17669398
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.
Imamura K; Ogura T; Kishimoto A; Kaminishi M; Esumi H
Biochem Biophys Res Commun; 2001 Sep; 287(2):562-7. PubMed ID: 11554766
[TBL] [Abstract][Full Text] [Related]
4. The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells.
Dagher Z; Ruderman N; Tornheim K; Ido Y
Biochem Biophys Res Commun; 1999 Nov; 265(1):112-5. PubMed ID: 10548499
[TBL] [Abstract][Full Text] [Related]
5. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
6. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
7. The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats.
Coyral-Castel S; Tosca L; Ferreira G; Jeanpierre E; Rame C; Lomet D; Caraty A; Monget P; Chabrolle C; Dupont J
J Neuroendocrinol; 2008 Mar; 20(3):335-46. PubMed ID: 18194429
[TBL] [Abstract][Full Text] [Related]
8. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
9. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
[TBL] [Abstract][Full Text] [Related]
11. AMPK regulation of the growth of cultured human keratinocytes.
Saha AK; Persons K; Safer JD; Luo Z; Holick MF; Ruderman NB
Biochem Biophys Res Commun; 2006 Oct; 349(2):519-24. PubMed ID: 16949049
[TBL] [Abstract][Full Text] [Related]
12. Activation of AMP-activated protein kinase (AMPK) inhibits fatty acid synthesis in bovine mammary epithelial cells.
McFadden JW; Corl BA
Biochem Biophys Res Commun; 2009 Dec; 390(3):388-93. PubMed ID: 19747896
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress.
Carraway RE; Hassan S
Regul Pept; 2007 Jun; 141(1-3):140-53. PubMed ID: 17289170
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats.
Ye JM; Dzamko N; Hoy AJ; Iglesias MA; Kemp B; Kraegen E
Diabetes; 2006 Oct; 55(10):2797-804. PubMed ID: 17003345
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase.
Kuo CL; Ho FM; Chang MY; Prakash E; Lin WW
J Cell Biochem; 2008 Feb; 103(3):931-40. PubMed ID: 17615555
[TBL] [Abstract][Full Text] [Related]
16. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
[TBL] [Abstract][Full Text] [Related]
17. Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.
Huypens P; Quartier E; Pipeleers D; Van de Casteele M
Eur J Pharmacol; 2005 Aug; 518(2-3):90-5. PubMed ID: 16039647
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
19. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
Du M; Shen QW; Zhu MJ; Ford SP
J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]